Free shipping over $200
All guides

As-Needed Use Guide

PT-141 (Bremelanotide)

PT-141 (Bremelanotide) is a melanocortin receptor agonist acting on the central nervous system, investigated for pro-sexual effects and arousal enhancement in both male and female research models.

Dosage protocol (U-100 insulin syringe)

Dose levelDoseFrequency
Beginner0.5 mg (50 units)As needed — max 1x per 24 hours
Standard1 mg (100 units)As needed — max 1x per 24 hours
Advanced2 mg (200 units)As needed — max 1x per 24 hours

Common research protocol: 0.5–2 mg injected subcutaneously, typically 30–45 minutes before the study window. Do not exceed one administration in any 24-hour period. Adjust based on individual response and study design.

How often to use

  • As needed — at most once in any 24-hour period.
  • Allow at least 24 hours between administrations.

How to administer

  • Reconstitute with bacteriostatic water.
  • Draw your dose with an insulin syringe.
  • Inject subcutaneously into the fat of the abdomen or thigh.
  • Rotate injection sites and use a new needle each time.

Storage

  • Store reconstituted vial in the refrigerator (2–8°C / 36–46°F).
  • Do not freeze.
  • Protect from light.
  • Use within 90 days after first puncture.
  • Keep the vial tightly sealed when not in use.

Common use

  • Studied for sexual dysfunction research
  • Acts on central melanocortin receptors
  • Investigated for arousal enhancement
  • Studied for both male and female applications

Important

  • For research use only – not for human or veterinary use.
  • Not for resale or distribution.
  • Keep out of reach of children.
  • Consult with a healthcare professional before use.
  • Discontinue use if adverse reactions occur.
  • Use sterile technique at all times.

How to inject

Reading your syringe

Doses on this site are written in units. A standard U-100 insulin syringe holds 100 units (1 mL). Each small line is 1 unit; each long numbered line is 10 units. Draw to the line where the black plunger tip stops.

U-100 insulin syringe with the 25 unit mark highlighted

Subcutaneous injection sites

Most peptides are injected subcutaneously — into the fat just under the skin. Common sites are the abdomen (avoid 2 inches around the navel), front outer thigh, outer upper arm, upper outer hip, or lower back. Clean the area, rotate sites, and use a new needle each time.

Subcutaneous injection sites: abdomen, thighs, upper arms, hips and lower back

Need PT-141 (Bremelanotide)?

10 mg vial

View product